| Date | Title | Description |
| 23.01.2021 | Implandata’s EYEMATE System Protects Glaucoma Patients – Even During Lockdown | People with glaucoma and eye doctors face a dilemma. On one hand, patients with glaucoma are at high risk of losing their eyesight if their disease progresses undetected and essential therapy adjustments are delayed. On the other hand, thes... |
| 12.01.2021 | Miracor Medical raises 24M€ | Miracor Medical raises 24M€
Funds will be used for clinical studies and initiation of commercialization
Awans, Belgium
Miracor Medical SA (Miracor Medical) has announced the closing of a 24M€ Series-E round of financing. The round was ... |
| 12.01.2021 | CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA® in gene therapy | CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA® in gene therapy
Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC) today announced the signing of a license agreement with Biogen Inc. (Biogen; Nasdaq... |
| - | British NICE Institute: Positive assessment of the Humedics LiMAx® test |
Berlin
The British National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing on the LiMAx® test. In particular, the briefing emphasises the innovative diagnostic capabilities of this novel breat... |
| - | CEVEC strengthens team to execute rapid growth strategy |
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the expansion and reorganization of its management team.
Dr. Nico Scheer will join the ... |
| - | CEVEC has been granted a new CAP®Go technology patent and reinforces its leading role in production of recombinant proteins previously out of reach |
Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that the Company has been granted a patent for its expression technology... |
| - | The LiMAx® test is now commercially available in the UK | Humedics receives UK Marketing Authorization for its diagnostic agent, LiMAxetin®, and thus achieves full market clearance for the LiMAx® maximum liver capacity test in the UK, – the company’s first in Europe!
Berlin, Germany
Humedics G... |
| - | CEVEC introduces CAP®Go expression system for scalable production of tailor-made glycoproteins | Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), a global solution and service provider for the production of biopharmaceuticals based on a unique human cellular expression system, today announced the introduction of the technology pla... |
| - | Miracor Medical raises € 25m | Funds will be used to support clinical and prepare commercial activities.
Company relocates from Austria to Belgium
Awans, Belgium and Vienna, Austria
Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical... |
| - | CEVEC intensifies its marketing activities, presenting at various renowned scientific conferences in Europe and the US | Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that the Company will present at the following renowned international scie... |
| - | Emperra Wins the 2017 Game Changers Award for Digital Business Models | Potsdam
Emperra GmbH, a start-up company based in Potsdam, Germany, has received the Finance Monthly’s 2017 Game Changers Award. The award is honouring Emperra for its new digital business models, which – based on innovative hardware – ena... |
| - | PVP appoints Dr. Markus Müschenich as Venture Partner for Digital Health | Markus Müschenich is a new Venture Partner of Peppermint VenturePartners (PVP). As an expert for Digital Health, he will be supporting the PVP team in the evaluation and guidance of young start-up companies. |
| - | Independent trial shows accurate staging of liver fibrosis with the LiMAx® test | Clinical study from the University of Essen reveals superiority of the LiMAx® test for noninvasively detecting different stages of fibrosis and cirrhosis in patients with chronic liver disease
Berlin, Germany, and Paris, France
Humedics... |
| - | Humedics submists Marketing authorizaion application for the diagnostic agent with the LiMAx test | Humedics GmbH, a specialist for real-time and mobile measurement of the individual liver function at the bedside of the patient, today announced that the company has submitted the marketing authorization application for the diagnostic agent... |
| - | CEVEC raises EUR 4.5 million in a financing round to commercialize its leading CAP(R) based technologies |
Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the successful completion of a financing round of EUR 4.5 million. New i... |
| - | Miracor Medical granted FDA Breakthrough Device Designation for the PiCSO Impulse System | Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for treatment of STEMI patients.
Awans, Belgium
The FDA Breakthrough Devi... |
| - | The Berlin Institute of Health adopts the digital laboratory data management platform from the Berlin-based start-up labfolder | The Berlin-based start-up labfolder has won a second major client: beginning in April 2017, the Berlin Institute of Health (BIH) will be introducing labfolder’s electronic lab notebook as part of its quality initiative. The innovative data ... |
| - | Expertise in the health insurance sector: AXA business strategist Dr. Tom Albert joins PVP Expert Panel | Dr. Tom Albert, Head of Strategy at AXA Krankenversicherung AG, becomes the fifth member of Peppermint Venture Partners’ (PVP’s) Expert Panel. The members of the Expert Panel support PVP in international benchmarking potential investments a... |
| - | Diabetes therapy 2.0 – The Bluetooth-enabled ESYSTA® Smart Insulin Pen and the ESYSTA® smartphone app in the last stages of the CE approval process. | Germany, Potsdam
The Potsdam-based EMPERRA® GmbH E-Health Technologies, specialized in digital health systems and Telediabetology, would like to call your attention to an important further development of the innovative, integrated telemoni... |
| - | CEVEC further strengthens organization to drive industrialization and commercialization of CAP(R) technologies |
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a strengthening of the Company reflective of its strategic progress.
Bart Bergstein, indu... |
| - | Peppermint VenturePartners closes Series-C financing round of Miracor Medical Systems GmbH | Berlin. Peppermint VenturePartners led the recent Series-C financing of Miracor Medical Systems GmbH with an investment from its Peppermint CBF-1 fund. The total amount raised in the Series-C is currently € 7 Million. Miracor seeks to compl... |
| - | CEVEC introduces CAP(R)GT cell-expression system for scalable viral gene therapy vector production | CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP(R)GT, for the fully scalable prod... |
| - | Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery | Clinical phase III trial at 6 specialized liver centers demonstrates impressive benefits of the LiMAx® test.
Berlin, Germany
Humedics GmbH, a specialist in real-time measurement of liver function capacity, announced results of a multice... |
| - | CEVEC and Beckman Research Institute of City of Hope enter into a cooperation and license agreement on CEVEC’s proprietary CAP(R)GT technology |
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a collaboration agreement with Beckman Research Institute of City of Hope (“Beckman Resear... |
| - | Miracor Medical starts PiCSO-AMI-I randomized study in EU | Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with conventional PCI for the treatment of anterior STEMI patients... |
| - | Appointment of Bent Johnsen as CEO for EMPERRA® | Potsdam
EMPERRA®, specializing in digital health solutions for people living with diabetes, has appointed Mr. Bent Johnsen as Managing Director and CEO.
Mr. Johnsen, a Danish national, has an extensive international career in the health c... |
| - | Peppermint VC realizes lucrative exit… | Berlin
Peppermint VC realizes lucrative exit through the acquisition of next-generation chemotherapy agent CAP7.1 from German biotech CellAct by Mundipharma
CellAct Pharma GmbH together with the Mundipharma global network has announced a ... |
| - | LiMAx test enables better timing of liver surgery for colorectal liver metastatic patients after chemotherapy | Berlin. Humedics GmbH, a specialist for real-time and mobile measurement of the individual liver function at the bedside of the patient, today announced that two studies show the potential of the LiMAx test to better assess the eligibility ... |
| - | CryoTherapeutics closes Series B financing round at EUR 7 million | Funds will be used to support clinical activities, R&D, international growth and establishing its operations in Belgium
Awans, Belgium and Cologne, Germany
CryoTherapeutics GmbH and CryoTherapeutics SA today announced the closing of... |
| - | CEVEC to introduce new helper-free AAV packaging cell line for scalable stable gene therapy vector production at the Phacilitate Cell & Gene Therapy World Conference |
Cologne
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that the Company will introduce a new solution for scalable stable viral vector p... |
| - | Documentary: Hypes and Hopes around digital health | There are around 8,000 health startups in the world. The industry is growing but how useful are the solutions? How many app/solutions makers know what they are doing? How much hype and how much hope is in digital health?
PVP-Managing Partn... |
| - | labfolder selected for the Merck Accelerator |
Berlin and Darmstadt. Over the next three months, the Berlin startup company labfolder will benefit from support, coaching and consulting after being chosen for the Merck Group´s global Accelerator. labfolder GmbH, which was founded in 20... |
| - | PVP adds Dr. Fred Schaebsdau former Head of Global Strategy and Business Development Roche Diabetes Care to its expert panel | Dr. Fred Schaebsdau will be assisting Peppermint VenturePartners (PVP) as a member of the PVP expert panel in the analysis of new investment opportunities, especially in the field of diagnostics, and will also be helping existing portfolio ... |
| - | Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch | Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today it successfully attained CE mark for its next generation EYEMATE-IO 1.1 implantable micro-sensor, which will be launched in April 2019. The C... |
| - | The LiMAx® liver capacity test is now commercially available in Germany, Austria and the UK | Following approval in the UK in 2017, Humedics has now also received Marketing Authorization for its diagnostic agent, LiMAxetin®, in Germany and Austria.
Berlin, Germany, and Paris, France
Humedics GmbH, a specialist in real-time measu... |
| - | With CE Mark for Glaucoma Microsensor in Pocket, Implandata Looks to US | - |
| - | Stoeckemann: “Finnish healthtech scene has done a better job than Germany” | Klaus Stoeckemann, PVP Managing Partner, joined Healthtech Invest Europe 2017 in Helsinki/Finland. Watch his opinion on why Finnland is far ahead of Germany when it comes to digitilizing healthcare:
|
| - | Medical Devices Group interviewing Klaus Stoeckemann on Caterna Vision | Joe Hage, Marketing Consultant of the Medical Device Group, the world’s largest medical device community, is interviewing PVPs Managing Partner Klaus Stoeckemann on Caterna Vision, an app reimbursed in Germany.
Read more:
http://www.medic... |
| - | Use of LiMAx test leads to reduction in post-hepatectomy liver failure and related mortality | Humedics GmbH, a specialist for real-time and mobile measurement of the individual liver function at the bedside of the patient, today announced results of a retrospective study investigating the impact of the LiMAx test on clinical patient... |
| - | CEVEC and BioLamina combine technology leadership for commercial production of recombinant laminins for ex vivo cell therapies |
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, and BioLamina AB, a leading manufacturer of high quality products for primary cell culture, announced toda... |
| - | labfolder Expands to North America and Initiates Collaboration with the German Accelerator Life Sciences | BERLIN & CAMBRIDGE, Mass. labfolder and the German Accelerator Life Sciences (GALS), an initiative supported by the German Federal Ministry for Economic Affairs and Energy (BMWi), today announced the initiation of an extensive collabora... |
| - | CEVEC’s CAP®Go derived recombinant placental human alkaline phosphatase shows superior results in a preclinical study |
Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins, today announced the results of a preclinical animal study in which its CAP®Go derived recombinant placental human... |
| - | Tackling the German Healthcare System | What are the latest trends in biotech and digital health funding and why is Germany still using fax machines in healthcare?
a podcast by Tjasa Zajc
with Klaus Stoeckemann, Managing Partner
Part 1
Part 2 |
| - | CEVEC announces appointment of life sciences industry expert Frank Ubags as Chief Executive Officer | Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), the provider of novel human cell expression systems, today announced the appointment of Frank Ubags as Chief Executive Officer starting immediately. He replaces Wolfgang Kintzel who is m... |
| - | Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication | Ophthalmic sensors and digital health company Implandata Ophthalmic Products GmbH (Implandata) announced today that it successfully attained CE mark for its EYEMATE system for use in patients undergoing keratoprosthesis surgery. Keratoprost... |
| - | CEVEC and CellGenix cooperation leads to expansion of CellGenix cytokine portfolio with CAP®Go technology-derived TGF-ß1 for ex vivo cell culture |
Cologne
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, is pleased to note that cooperation partner CellGenix, a leading global supplier of GMP raw mater... |
| - | PVP expands its portfolio by labfolder – the digital laboratory notebook software for research | Berlin
The Charité Biomedical Fund (CBF-1), managed by Peppermint VenturePartners (PVP), is the lead investor of the current financing round of labfolder – the digital laboratory notebook software for research. labfolder closes a seven-dig... |
| - | Labfolder signs Agreement with Max Planck Society for organization-wide use of laboratory data digital platform |
Berlin/Munich. labfolder GmbH and the Max Planck Society announced today a licensing agreement to provide up to 11,000 Max Planck scientists with labfolder’s laboratory data management digital platform. This is the first time that a tool ... |
| - | Helmholtz validation funding extended, facilitating further projects | Developing pioneering technologies and making them attractive for industry often requires a great deal of patience and perseverance. The Helmholtz Validation Fund (HVF) is therefore providing support to a number of particularly promising pr... |
| - | Biotech platform: Interview with CEVEC pharmaceuticals | The CSO of PVPs Portfolio Company CEVEC pharmaceuticals, Nicole Faust, was interviewed by labbiotech.eu – the leading digital media covering the European biotech industry – on CEVECS CAP Technology and it’s fight against the Zika Virus.
Re... |
| - | Laboratory IT solution provider Labforward announces major rebranding at BCEIA in Beijing, China | At the Beijing Conference and Exhibition on Instrument Analysis (BCEIA), a leading Chinese trade fair for laboratory instruments, Labforward today announced a major rebranding to unify its products under a clear, clean identity. From today,... |
| - | CEVEC’s CAP®GT sets a new standard through RCA-free production of adenoviral vectors for gene therapy applications | CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that the Company’s proprietary cell-expression system, CAP®GT, has delivered the production ... |
| - | Lab Notebook learns to communicate with laboratory devices: labfolder acquires cubuslab and becomes Labforward | labfolder GmbH from Berlin and the cubuslab GmbH from Karlsruhe are merging. As a new company called Labforward, they jointly develop a manufacturer-independent platform for the integration of laboratory equipment and laboratory control sof... |
| - | CEVEC closes major financing round to further expand and commercialize its viral vector manufacturing platform |
Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycopro- teins and gene therapy vectors, today announced the successful closing of a Series D financing round with new and exis... |
| - | Successful financing round: PVP makes a further investment in Caterna Vision | Berlin, 27.07.2015. Caterna Vision GmbH has successfully completed a further financing round in July 2015 led by the Peppermint Charité Biomedical Fund (CBF-1), which is managed by Peppermint VenturePartners (PVP). The investors were partic... |
| - | Humedics Announces Appointment of Karsten Damgaard-Iversen as CEO | Berlin. The Board of Humedics GmbH is pleased to announce a reinforcement of the senior team of the company with Karsten Damgaard-Iversen (MBA, BScEE), who will take up the role of CEO as of June 1, 2017. Erwin de Buijzer will stay on as ma... |
| - | CEVEC submits Biologics Master File (BB-MF) for CAP(R) Technology to the U.S. FDA |
Cologne. CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that is has submitted a Biologics Master File (BB-MF) for its human cell substrat... |
| - | Startup platform WUNDERDING calls Emperra “most promising startup” | WUNDERDING – a platform about science and tech startups, supported by Robert Bosch Stiftung – calls PVP’s portfolio company Emperra “startup of the week”
Read more:
http://www.wunderding.co/projects |
| - | CEVEC licenses CAP(R) technologies for the development and commercialization of vaccines against Zika Virus infections | Cologne. CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that it has signed an exclusive license agreement with NewLink Genetics (NASDAQ:NLN... |
| - | CEVEC Appoints New Management Team | Cologne, Germany Wolfgang Kintzel remains Chief Executive Officer, Dr. Nicole Faust is appointed Chief Scientific Officer, Dr. Hartmut Tintrup is appointed Chief Business Officer and Frank Ubags joins as Chief Operating Officer. “Our vision... |
| - | First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring | Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today that the first patient in its international, multi-center, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure ... |
| - | Humedics closes 6.3 million € financing round | Berlin, Germany Humedics GmbH, a specialist for real-time and mobile measurement of the individual liver function at the bedside of the patient, today announced the closing of a Series C financing round totaling more than 6.3 million Euro. ... |
| - | First Keratoprosthesis Patient in Europe Receives Permanent 24h Intraocular Pressure Sensor EyeMate | Munich and Hannover, Germany
Implandata Ophthalmic Products GmbH (Implandata) announces the successful implantation of Implandata’s EyeMate intraocular pressure sensor at a first patient in Europe undergoing keratoprosthesis surgery. The i... |
| - | CEVEC and PlasmidFactory announce collaboration regarding adeno-associated virus (AAV) production |
Cologne. CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that the Company will collaborate with PlasmidFactory, the leading contract manuf... |
| - | Emperra Digital Diabetes Care closes Series B round with Robert Bosch Venture Capital GmbH joining as a new investor | Emperra, a German start-up that has created a digital diabetes management solution consisting of smart hardware and software, has completed a Series B financing round of USD 3.1 million, with Robert Bosch Venture Capital GmbH (RBVC), a corp... |
| - | Business Worldwide-Interview with CEO of PVPs Portfolio Company Emperra | Christian Krey, CEO of PVPs Portfolio Company Emperra, in interview with the Business Worldwide Magazine.
BWM’s article:
|
| - | CEVEC and Paragon Bioservices enter into comprehensive collaboration to roll out CAP(R) technologies in North America |
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors and Paragon Bioservices, Inc., a leader in the manufacturing of biopharmaceuticals and vaccines, today anno... |
| - | CEVEC and Généthon sign a collaboration agreement to develop lentiviral vector packaging cell lines based on CEVEC’s proprietary CAP®GT technology |
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a collaboration agreement with Généthon (Evry, France) for the development and exploitatio... |
| - | Emperra Wins Prestigious Award With Innovative Diabetes Device | London. Emperra GmbH E-Health Technologies was announced Business Worldwide Magazine’s (BWM) 2016 Company of the Year Award/Medical Device Industry Europe for its innovative diabetes management system. The device, known as ESYSTA® combines ... |
| - | CEVEC grants license to Biotest AG for production of tailor-made glycoproteins | Cologne, Germany
CEVEC Pharmaceuticals GmbH (CEVEC), an expert for the production of glyco-optimized biopharmaceuticals, today announced that it has granted a license for its proprietary CAP(R)Go technology to Biotest AG for the developmen... |
| - | CEVEC and CellGenix sign collaboration and license agreement for CEVEC’s proprietary CAP®Go technology | Cologne and Freiburg
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, and CellGenix GmbH, a leading manufacturer of premium-grade reagents for clinical cell... |
| - | CEVEC, medac and Provecs Medical enter into far-reaching adenoviral vector collaboration in oncology | CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, Provecs Medical GmbH (Provecs), a biopharmaceutical company specialized in the development of cancer microen... |
| - | IOP Launched Pre-Clinical Studies for 24h Extraocular Sensor | Hannover, Germany Implandata Ophthalmic Products GmbH (Implandata) and Professor Peter Szurman, Head of “Section Experimental Ophthalmic Surgery” at Eye Hospital of University Tübingen, have started pre-clinical studies for the first implan... |
| - | Scalable production of gene therapy vectors: an interview with Frank Ubags | Frank Ubags, CEO of PVPs Portfolio Company CEVEC Pharmaceuticals GmbH, talks about the production of scene therapy vectors. An interview with News Medical.
The Interview: |
| - | Go for quality: New Center for Biohybrid Medical Systems at RWTH Aachen University embarks on digital data management | Together with labfolder, the NRW Priority Professorship Biohybride and Medical Textiles in the new Center for Biohybrid Medical Systems at the RWTH Aachen University embarks on digital data management. Goals are the protection and traceabil... |
| - | Hypes and hopes around digital health | What is digital health? How big is the industry? Is it all a hype or a serious disruptive innovation storm that will fundamentally change global healthcare?
PVP-Managing Partner Klaus Stoeckemann and other entrepreneurs on what digital hea... |